Regeneron Pharmaceuticals Non-GAAP EPS of $11.83 beats by $2.19, revenue of $3.75B beats by $160M (NASDAQ:REGN)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...